These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 28371247

  • 1. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Aug; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 4. New medications for heart failure.
    Gordin JS, Fonarow GC.
    Trends Cardiovasc Med; 2016 Aug; 26(6):485-92. PubMed ID: 27038558
    [Abstract] [Full Text] [Related]

  • 5. Ivabradine in heart failure: hope or hype?
    Deedwania PC.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):357-9. PubMed ID: 23181943
    [No Abstract] [Full Text] [Related]

  • 6. Update on ivabradine for heart failure.
    Borer JS, Tavazzi L.
    Trends Cardiovasc Med; 2016 Jul 01; 26(5):444-9. PubMed ID: 26934996
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D, Borer JS.
    Drugs; 2007 Jul 01; 67 Suppl 2():15-24. PubMed ID: 17999560
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 15. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M, Abdin A, Slawik J, Mahfoud F, Borer J, Ford I, Swedberg K, Tavazzi L, Batailler C, Komajda M.
    Eur J Heart Fail; 2023 Aug 29; 25(8):1429-1435. PubMed ID: 37092340
    [Abstract] [Full Text] [Related]

  • 16. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A, Makharadze T, Gvishiani M.
    Georgian Med News; 2015 Apr 29; (241):44-9. PubMed ID: 25953938
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D, Savarese G, Dahlström U, Fu M, Howlett J, Ezekowitz JA, Lund LH.
    Circ Heart Fail; 2017 Sep 29; 10(9):. PubMed ID: 28903983
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL, Francis KE, Lowe DK, Cahoon WD.
    Ther Adv Cardiovasc Dis; 2016 Dec 29; 10(6):348-352. PubMed ID: 27659287
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.